Teleflex (TFX)
(Delayed Data from NYSE)
$222.49 USD
-2.08 (-0.93%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $222.48 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Teleflex Incorporated [TFX]
Reports for Purchase
Showing records 201 - 220 ( 472 total )
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Everything Positive Except Level of UroLift Outperformance
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
A Sigh of Relief in Proposed HOPD/ASC Reimbursement
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Company: Teleflex Incorporated
Industry: Medical - Instruments
Addressing Key Questions on UroLift Reimbursement
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Some Unfavorable Proposed Changes to UroLift Codes in the CY22 Proposed Physician Fee Schedule
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Comprehensive Technical and Fundamental Analysis for TFX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teleflex Incorporated
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department